Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,585 | 1,398 | 99.9% |
| Education | $32.07 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,811 | 76 | $0 (2024) |
| Novo Nordisk Inc | $2,688 | 181 | $0 (2024) |
| ABBVIE INC. | $2,112 | 129 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,571 | 96 | $0 (2024) |
| Lilly USA, LLC | $1,358 | 103 | $0 (2024) |
| PFIZER INC. | $1,317 | 64 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,216 | 66 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $994.96 | 72 | $0 (2022) |
| Merck Sharp & Dohme LLC | $932.57 | 104 | $0 (2024) |
| Amarin Pharma Inc. | $922.01 | 57 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,913 | 197 | AstraZeneca Pharmaceuticals LP ($655.69) |
| 2023 | $4,731 | 225 | AstraZeneca Pharmaceuticals LP ($625.04) |
| 2022 | $3,131 | 196 | ABBVIE INC. ($491.30) |
| 2021 | $3,213 | 224 | AbbVie Inc. ($396.46) |
| 2020 | $1,762 | 108 | Novo Nordisk Inc ($427.12) |
| 2019 | $2,542 | 125 | AstraZeneca Pharmaceuticals LP ($351.40) |
| 2018 | $2,421 | 144 | GlaxoSmithKline, LLC. ($334.99) |
| 2017 | $2,904 | 183 | Amarin Pharma Inc. ($269.87) |
All Payment Transactions
1,402 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $0.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.31 | General |
| Category: DIABETES | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: UROLOGY | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $0.15 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Obesity | ||||||
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Biological | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $9.48 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Cardio-renal | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 339 | 518 | $80,030 | $29,655 |
| 2022 | 9 | 390 | 540 | $94,788 | $35,255 |
| 2021 | 12 | 467 | 693 | $113,560 | $49,001 |
| 2020 | 13 | 444 | 619 | $96,850 | $34,250 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 161 | $37,835 | $12,122 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 78 | 78 | $15,600 | $9,557 | 61.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 121 | $22,990 | $6,023 | 26.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 16 | $1,200 | $1,147 | 95.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 16 | $544.00 | $469.76 | 86.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 44 | 58 | $986.00 | $191.64 | 19.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 19 | $532.00 | $141.92 | 26.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 12 | 49 | $343.00 | $2.82 | 0.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 190 | $44,650 | $14,243 | 31.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 74 | 74 | $14,800 | $9,312 | 62.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 87 | 139 | $26,410 | $6,700 | 25.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 12 | 12 | $2,580 | $1,942 | 75.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 27 | 27 | $2,025 | $1,847 | 91.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 29 | 29 | $986.00 | $811.12 | 82.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 24 | $672.00 | $228.34 | 34.0% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 20 | 20 | $2,240 | $86.36 | 3.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 24 | 25 | $425.00 | $85.36 | 20.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 96 | 192 | $45,120 | $17,467 | 38.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 98 | 98 | $19,600 | $12,666 | 64.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 178 | $33,820 | $9,201 | 27.2% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 19 | 22 | $4,400 | $3,561 | 80.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 13 | 13 | $2,795 | $2,155 | 77.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 29 | 29 | $2,175 | $1,893 | 87.0% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 18 | 18 | $630.00 | $630.00 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 34 | 34 | $1,156 | $550.34 | 47.6% |
About Dr. William Cox, MD
Dr. William Cox, MD is a Family Medicine healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1902946858.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Cox, MD has received a total of $24,617 in payments from pharmaceutical and medical device companies, with $3,913 received in 2024. These payments were reported across 1,402 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($24,585).
As a Medicare-enrolled provider, Cox has provided services to 1,640 Medicare beneficiaries, totaling 2,370 services with total Medicare billing of $148,162. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Cincinnati, OH
- Active Since 02/08/2007
- Last Updated 01/18/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1902946858
Products in Payments
- JARDIANCE (Drug) $1,621
- Ozempic (Drug) $1,246
- FARXIGA (Drug) $995.38
- BREZTRI (Drug) $958.81
- Vascepa (Drug) $922.01
- VRAYLAR (Drug) $815.27
- ELIQUIS (Drug) $722.37
- XARELTO (Drug) $677.84
- AFREZZA (Drug) $641.10
- QULIPTA (Drug) $639.52
- NURTEC ODT (Drug) $637.92
- MOUNJARO (Drug) $545.65
- Kerendia (Drug) $541.90
- Rybelsus (Drug) $495.27
- JANUVIA (Drug) $480.29
- UBRELVY (Drug) $455.66
- XIFAXAN (Drug) $450.65
- ENTRESTO (Drug) $409.39
- TRELEGY ELLIPTA (Drug) $336.16
- AREXVY (Drug) $331.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cincinnati
Michael Heile, Md, MD
Family Medicine — Payments: $382,686
Amy Mechley, Md, MD
Family Medicine — Payments: $277,547
Paul Nugent, D.o, D.O
Family Medicine — Payments: $159,309
Melissa Schroer, Md, MD
Family Medicine — Payments: $147,431
Dr. Shayla Pullen, Md, MD
Family Medicine — Payments: $32,310
Mr. Don Fixler, Md, MD
Family Medicine — Payments: $18,502